Outset Medical (NASDAQ: OM) is one of 65 publicly-traded companies in the “Electromedical equipment” industry, but how does it weigh in compared to its competitors? We will compare Outset Medical to related companies based on the strength of its analyst recommendations, institutional ownership, dividends, risk, profitability, valuation and earnings.
This table compares Outset Medical and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Outset Medical Competitors||-248.11%||-29.16%||-15.64%|
83.5% of Outset Medical shares are held by institutional investors. Comparatively, 47.7% of shares of all “Electromedical equipment” companies are held by institutional investors. 12.9% of shares of all “Electromedical equipment” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Earnings & Valuation
This table compares Outset Medical and its competitors gross revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Outset Medical||$49.94 million||-$121.49 million||-9.95|
|Outset Medical Competitors||$999.91 million||$94.29 million||136.92|
Outset Medical’s competitors have higher revenue and earnings than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
This is a summary of recent ratings and target prices for Outset Medical and its competitors, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Outset Medical Competitors||211||883||1677||37||2.55|
Outset Medical currently has a consensus target price of $58.20, indicating a potential upside of 20.55%. As a group, “Electromedical equipment” companies have a potential upside of 16.41%. Given Outset Medical’s stronger consensus rating and higher possible upside, analysts clearly believe Outset Medical is more favorable than its competitors.
Outset Medical beats its competitors on 7 of the 12 factors compared.
About Outset Medical
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It offers Tablo Hemodialysis System, which comprises of a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Receive News & Ratings for Outset Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Outset Medical and related companies with MarketBeat.com's FREE daily email newsletter.